News & Events

This video was recorded on 14 January 2021 with Professor Anne-Marie Tobin (Consultant Dermatologist at Tallaght University Hospital and HSE Clinical Lead for Dermatology) to discuss some frequently asked questions people with skin conditions have about the COVID-19 vaccines. For more COVID-19 vaccine information please visit: www2.hse.ie/covid-19-vaccine/ COVID-19 information For information and guidance on Covid-19 please visit the HSE website and our information […]

More

By Michelle Greenwood The Irish Skin Foundation are delighted to collaborate with the International Federation of Psoriasis Associations (IFPA) and Novartis on the launch of Psoriasis and Beyond: The Global Psoriatic Disease Survey, a research initiative to uncover what life is like for people living with moderate-to-severe psoriatic disease—psoriasis or psoriatic arthritis—around the world. The […]

More

Fewer than one in five people with psoriasis in Ireland is aware of their increased risk of heart and bowel disease, according to a new study. The study, carried out at University Hospital Waterford, examined patient awareness of co-morbidities associated with psoriasis. What is psoriasis? Psoriasis is an inflammatory condition that causes red, dry, flaky or scaly skin and […]

More

Eczema Awareness Week is held in September. It coincides with the start of the school year when many households will be adapting to a new routine for children starting or returning to school.  With all the excitement and preparation, we are mindful of the children out there with eczema and what this might mean for them. This year […]

More

Ireland among last countries in EU to make new drug available to patients The ISF is calling on HSE management to reimburse a first-in-class drug (dupilumab) to provide access to hundreds of people living with severe atopic eczema throughout Ireland. In 2017, the European Medicines Agency approved dupilumab (brand name: Dupixent) for the treatment of moderate-to-severe atopic […]

More